Transthyretin is a novel innate immune effector against Gram negative bacteria.

Bernabé T, Verd M, Ramis G, González-Alsina A, Qadi M, Mateu-Borrás M, Doménech-Sánchez A, Albertí S

Open source

DOI
10.1371/journal.ppat.1014086
Published
2026 Mar
Container
PLoS pathogens
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.ppat.1014086,
  title = {Transthyretin is a novel innate immune effector against Gram negative bacteria.},
  author = {Bernabé T and Verd M and Ramis G and González-Alsina A and Qadi M and Mateu-Borrás M and Doménech-Sánchez A and Albertí S},
  year = {2026},
  journal = {PLoS pathogens},
  doi = {10.1371/journal.ppat.1014086},
  url = {https://doi.org/10.1371/journal.ppat.1014086}
}

RIS

TY  - JOUR
TI  - Transthyretin is a novel innate immune effector against Gram negative bacteria.
AU  - Bernabé T
AU  - Verd M
AU  - Ramis G
AU  - González-Alsina A
AU  - Qadi M
AU  - Mateu-Borrás M
AU  - Doménech-Sánchez A
AU  - Albertí S
PY  - 2026
JO  - PLoS pathogens
DO  - 10.1371/journal.ppat.1014086
UR  - https://doi.org/10.1371/journal.ppat.1014086
ER  - 

APA

T, B., M, V., G, R., A, G., M, Q., M, M., A, D., & S, A. (2026). Transthyretin is a novel innate immune effector against Gram negative bacteria.. PLoS pathogens. https://doi.org/10.1371/journal.ppat.1014086

Source records